263 related articles for article (PubMed ID: 35106856)
1. Fusion-associated carcinomas of the breast: Diagnostic, prognostic, and therapeutic significance.
Loo SK; Yates ME; Yang S; Oesterreich S; Lee AV; Wang XS
Genes Chromosomes Cancer; 2022 May; 61(5):261-273. PubMed ID: 35106856
[TBL] [Abstract][Full Text] [Related]
2. Landscape analysis of adjacent gene rearrangements reveals BCL2L14-ETV6 gene fusions in more aggressive triple-negative breast cancer.
Lee S; Hu Y; Loo SK; Tan Y; Bhargava R; Lewis MT; Wang XS
Proc Natl Acad Sci U S A; 2020 May; 117(18):9912-9921. PubMed ID: 32321829
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic role of recurrent ESR1-CCDC170 gene fusions in breast cancer endocrine resistance.
Li L; Lin L; Veeraraghavan J; Hu Y; Wang X; Lee S; Tan Y; Schiff R; Wang XS
Breast Cancer Res; 2020 Aug; 22(1):84. PubMed ID: 32771039
[TBL] [Abstract][Full Text] [Related]
4. MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene.
Kim J; Geyer FC; Martelotto LG; Ng CK; Lim RS; Selenica P; Li A; Pareja F; Fusco N; Edelweiss M; Kumar R; Gularte-Merida R; Forbes AN; Khurana E; Mariani O; Badve S; Vincent-Salomon A; Norton L; Reis-Filho JS; Weigelt B
J Pathol; 2018 Feb; 244(2):143-150. PubMed ID: 29149504
[TBL] [Abstract][Full Text] [Related]
5. Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms.
Brill LB; Kanner WA; Fehr A; Andrén Y; Moskaluk CA; Löning T; Stenman G; Frierson HF
Mod Pathol; 2011 Sep; 24(9):1169-76. PubMed ID: 21572406
[TBL] [Abstract][Full Text] [Related]
6. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.
Mitani Y; Liu B; Rao PH; Borra VJ; Zafereo M; Weber RS; Kies M; Lozano G; Futreal PA; Caulin C; El-Naggar AK
Clin Cancer Res; 2016 Feb; 22(3):725-33. PubMed ID: 26631609
[TBL] [Abstract][Full Text] [Related]
7. Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling.
Andersson MK; Afshari MK; Andrén Y; Wick MJ; Stenman G
J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28954282
[TBL] [Abstract][Full Text] [Related]
8. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck.
Persson M; Andrén Y; Mark J; Horlings HM; Persson F; Stenman G
Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18740-4. PubMed ID: 19841262
[TBL] [Abstract][Full Text] [Related]
9. IGF2/IGF1R Signaling as a Therapeutic Target in MYB-Positive Adenoid Cystic Carcinomas and Other Fusion Gene-Driven Tumors.
Andersson MK; Åman P; Stenman G
Cells; 2019 Aug; 8(8):. PubMed ID: 31426421
[TBL] [Abstract][Full Text] [Related]
10. Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers.
Wetterskog D; Lopez-Garcia MA; Lambros MB; A'Hern R; Geyer FC; Milanezi F; Cabral MC; Natrajan R; Gauthier A; Shiu KK; Orr N; Shousha S; Gatalica Z; Mackay A; Palacios J; Reis-Filho JS; Weigelt B
J Pathol; 2012 Jan; 226(1):84-96. PubMed ID: 22015727
[TBL] [Abstract][Full Text] [Related]
11. Locally Recurrent Secretory Carcinoma of the Breast with NTRK3 Gene Fusion.
Mortensen L; Ordulu Z; Dagogo-Jack I; Bossuyt V; Winters L; Taghian A; Smith BL; Ellisen LW; Kiedrowski LA; Lennerz JK; Bardia A; Spring LM
Oncologist; 2021 Oct; 26(10):818-824. PubMed ID: 34176200
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of 1p36 locus deletion in adenoid cystic carcinoma of the salivary glands.
Šteiner P; Andreasen S; Grossmann P; Hauer L; Vaněček T; Miesbauerová M; Santana T; Kiss K; Slouka D; Skálová A
Virchows Arch; 2018 Oct; 473(4):471-480. PubMed ID: 29619555
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance.
Mitani Y; Li J; Rao PH; Zhao YJ; Bell D; Lippman SM; Weber RS; Caulin C; El-Naggar AK
Clin Cancer Res; 2010 Oct; 16(19):4722-31. PubMed ID: 20702610
[TBL] [Abstract][Full Text] [Related]
14. Fusion oncogenes in salivary gland tumors: molecular and clinical consequences.
Stenman G
Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S12-9. PubMed ID: 23821214
[TBL] [Abstract][Full Text] [Related]
15. Adenoid cystic carcinoma: emerging role of translocations and gene fusions.
Wysocki PT; Izumchenko E; Meir J; Ha PK; Sidransky D; Brait M
Oncotarget; 2016 Oct; 7(40):66239-66254. PubMed ID: 27533466
[TBL] [Abstract][Full Text] [Related]
16. New developments in the molecular pathogenesis of head and neck tumors: a review of tumor-specific fusion oncogenes in mucoepidermoid carcinoma, adenoid cystic carcinoma, and NUT midline carcinoma.
Bhaijee F; Pepper DJ; Pitman KT; Bell D
Ann Diagn Pathol; 2011 Feb; 15(1):69-77. PubMed ID: 21238915
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of Myb protein and downstream target genes in salivary adenoid cystic carcinoma.
Bell D; Roberts D; Karpowicz M; Hanna EY; Weber RS; El-Naggar AK
Cancer Biol Ther; 2011 Oct; 12(7):569-73. PubMed ID: 21785271
[TBL] [Abstract][Full Text] [Related]
18. Problematic breast tumors reassessed in light of novel molecular data.
Pareja F; Weigelt B; Reis-Filho JS
Mod Pathol; 2021 Jan; 34(Suppl 1):38-47. PubMed ID: 33024304
[TBL] [Abstract][Full Text] [Related]
19. The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer.
Vitale SR; Ruigrok-Ritstier K; Timmermans AM; Foekens R; Trapman-Jansen AMAC; Beaufort CM; Vigneri P; Sleijfer S; Martens JWM; Sieuwerts AM; Jansen MPHM
BMC Cancer; 2022 Feb; 22(1):165. PubMed ID: 35151276
[TBL] [Abstract][Full Text] [Related]
20. Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma.
Brayer KJ; Frerich CA; Kang H; Ness SA
Cancer Discov; 2016 Feb; 6(2):176-87. PubMed ID: 26631070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
